Phase 1 × Unspecified Adult Solid Tumor, Protocol Specific × Oxaliplatin × Clear all Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
Phase 1 Completed
74 enrolled
Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
Phase 1 Completed
Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
46 enrolled
Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery
Phase 1 Completed
50 enrolled
Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
Phase 1 Completed
84 enrolled
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
Phase 1 Unknown
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
30 enrolled
Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
Phase 1 Terminated
30 enrolled
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors
Phase 1 Completed
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
22 enrolled
Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
Phase 1 Completed
Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
Phase 1 Completed
Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
Phase 1 Completed
Capecitabine, Irinotecan, and Oxaliplatin in Treating Patients With Metastatic Cancer
Phase 1 Unknown
33 enrolled